New eye scanner aims to sharpen view of retinal disease
NCT ID NCT06269666
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This trial tests a new device called P200TxE that takes detailed images of the back of the eye. Researchers want to see how well it captures images in people with retinal diseases like glaucoma or macular degeneration. The study involves adults aged 22 and older who have been diagnosed with a retinal condition. The main goal is simply to collect images, not to treat any disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better detect and track retinal diseases like glaucoma and macular degeneration.
- What could go wrong
- This is an early image-collection study, not a treatment trial. It may not lead to direct improvements in patient care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Bennett and Bloom Eye Centers
Louisville, Kentucky, 40215, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a bangkok community eye check reveal hidden glaucoma risks?
- AI eye exam: a new hope for early glaucoma detection?
- Can a tiny eye implant replace glaucoma drops?
- Can a new tube implant surgery outperform standard glaucoma surgery?
- Could your personality predict glaucoma drug side effects?
- Could a single eye implant replace years of glaucoma drops?